LIFECARE ASA
LIFE
ADDITIONAL REGULATED INFORMATION REQUIRED TO BE DISCLOSED UNDER THE LAWS OF A MEMBER STATE
Lifecare ASA Ex. subscription rights today
Issuer name: Lifecare ASA
Ex. date: 5 January 2026
Type of corporate action: Partially underwritten preferential rights issue
Other information: The shares in Lifecare ASA will from today, 5 January 2026, be traded exclusive of the right to receive subscription rights for shares in the partially underwritten preferential rights issue announced on 22 October 2025.
This information is published in accordance with the requirements of the Continuing Obligations for companies listed on Euronext Oslo Børs.
About us Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare's focus is to bring the next generation of Continuous Glucose Monitoring systems to market. Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor technology is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.
Contacts For further information, please contact:
Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40
Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42
This information is subject to disclosure under the Norwegian Securities Trading Act, §5-12. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-01-05 07:00 CET.